| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |